Systematic multiomics analysis and in vitro experiments suggest that ITGA5 could serve as a promising therapeutic target for ccRCC.

MLA

Che, Xiangxian, et al. “Systematic Multiomics Analysis and in Vitro Experiments Suggest That ITGA5 Could Serve as a Promising Therapeutic Target for CcRCC.” Cancer Cell International, vol. 24, no. 1, Nov. 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s12935-024-03546-4.

APA

Che, X., Tian, X., Wang, Z., Zhu, S., Ye, S., Wang, Y., Chen, Y., Huang, Y., Anwaier, A., Yao, P., Chen, Y., Wu, K., Liu, Y., Xu, W., Zhang, H., & Ye, D. (2024). Systematic multiomics analysis and in vitro experiments suggest that ITGA5 could serve as a promising therapeutic target for ccRCC. Cancer Cell International, 24(1), 1–18. https://doi.org/10.1186/s12935-024-03546-4

Chicago

Che, Xiangxian, Xi Tian, Zhenda Wang, Shuxuan Zhu, Shiqi Ye, Yue Wang, Yihan Chen, et al. 2024. “Systematic Multiomics Analysis and in Vitro Experiments Suggest That ITGA5 Could Serve as a Promising Therapeutic Target for CcRCC.” Cancer Cell International 24 (1): 1–18. doi:10.1186/s12935-024-03546-4.